Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)

Rie Ozeki, Hirotoshi Iihara, Mototsugu Shimokawa, Hironobu Hashimoto, Masakazu Abe, Toru Mukohara, Hiroko Bando, Toshinobu Hayashi, Hitoshi Kawazoe, Masayo Komoda, Takako Yanai Takahashi, Mitsue Saito

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)'. Together they form a unique fingerprint.

Medicine & Life Sciences